Regulation & Compliance

OneShield's new AI platform lets insurers use advanced AI without replacing core systems, tackling the industry's biggest modernization hurdles.

As credential theft bypasses MFA, ThreatLocker launches a new Zero Trust solution that binds access to the device itself, aiming to neutralize phishing.

Gubernatorial hopeful Mandela Barnes faces a 'no sugar-coating' interview with Jay Walker. Can this podcast moment redefine his campaign for Wisconsin?

Lighthouse's new AI platform saves millions and finds key documents 40x faster, reshaping the high-stakes world of legal eDiscovery. But what does it mean?

MDClone launches ADAMS Copilot, a GenAI tool letting clinicians analyze data with simple questions, all while keeping sensitive information safe on-site.

Amid a 400% surge in ransomware targeting SAP, Onapsis and partners like Microsoft will tackle the security crisis driven by AI and cloud adoption.

A new multi-year deal gives RNAi leader Alnylam access to Helix's vast genomic and clinical data, aiming to redefine the speed of drug discovery.

With data from 150M patients, SEQSTER's new platform promises to accelerate drug development, improve trial diversity, and make research-ready data a reality.

With a 373% revenue spike and key hires, AI platform Hebbia is rapidly moving from experiment to essential tool for Europe's top financial firms.

Ripple Prime partners with Coinbase and Nodal Clear, offering clients access to regulated crypto derivatives in a major move for institutional adoption.

A top Molina Healthcare executive is now President at HiLabs, signaling a major push to use AI to fix the flawed data plaguing the health industry.

VistaPrint's new free AI tool promises pro logos in minutes, empowering entrepreneurs and challenging the traditional design landscape. Here's what it means.

As AI enters the courtroom, a Legalweek panel tackles the agentic and generative tech transforming complex cases and the urgent ethical dilemmas that follow.

Newly published research brings scientific rigor to the controversial kratom plant, influencing policy from the FDA to statehouses across the nation.

A new survey finds AI makes procurement teams 3.7x more resilient, yet many leaders are held back by a dangerous overconfidence in their own knowledge.

With a melanoma drug on track for 2027 and a deep pipeline, Immatics' 2025 net loss is part of a larger strategy to dominate PRAME cancer therapy.

With a new outpatient model, NexCure aims to bring life-saving cancer treatments like CAR-T closer to home, tackling a major healthcare bottleneck.

The healthcare provider posted robust annual growth and cash flow, but a tough Q4 and a prudent 2026 forecast reveal deepening industry-wide pressures.

The new iPSC-derived sensory neurons offer a reproducible human model, aiming to fix the broken pipeline of pain research and accelerate new analgesics.

From a solo practice to a legal titan, D.Law unveils a state-of-the-art Pasadena headquarters, a testament to its rapid growth and unique workplace culture.